Assessment of survival in patients with idiopathic pulmonary fibrosis ...

CT-histogram derived indexes may provide an accurate estimation of survival in IPF patients. They demonstrate a correlation with PFTs, highlighting their ...

Comparison of the quantitative CT imaging biomarkers of idiopathic pulmonary fibrosis at baseline and early change with an interval of 7 months.

Assessment of survival in patients with idiopathic pulmonary fibrosis ...

Conclusions: CT-histogram derived indexes may provide an accurate estimation of survival in a population of IPF patients since the time of diagnosis. Footnotes.

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis

The purpose of the multifactorial ROSE is to risk-stratify patients in order to predict survival and detect rapid disease progression. Idiopathic pulmonary ...

Comorbidity burden and survival in patients with idiopathic ...

Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple comorbidities, which may influence survival but go under-recognised in clinical ...

Outcome of patients who were incidentally diagnosed with idiopathic ...

Idiopathic pulmonary fibrosis (IPF) is a fatal and progressive fibrosing interstitial pneumonia of unknown cause [1]. Although the clinical courses of patients ...

Clinical Course and Prediction of Survival in Idiopathic Pulmonary ...

Idiopathic pulmonary fibrosis (IPF) is a progressive, life-threatening, interstitial lung disease of unknown etiology. The median survival ...

Baseline characteristics and survival of patients with idiopathic ...

The cumulative mortality rate in the whole cohort in year 1, 2, 3, 4 and 5 was 91%, 79%, 64%, 59% and 42%, respectively. Baseline lung function (FVC%, FEV1%, ...

Relationship between survival and age in patients with idiopathic ...

Idiopathic pulmonary fibrosis (IPF) has an overall poor prognosis. The median survival time of patients with IPF was 2–3 years from the time of diagnosis, in ...

Safety and survival data in patients with idiopathic pulmonary ...

Based on the Weibull distribution, mean (95% CI) survival was estimated as 11.6 (9.6, 14.1) years in nintedanib-treated patients and 3.7 (2.5, ...

Survival and acute exacerbation for patients with idiopathic ...

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year ...

Predicting survival of patients with idiopathic pulmonary fibrosis ...

Morbidity and mortality are high in IPF—the median survival time is only 2.5 to 3.5 years—and the clinical course and prognosis vary widely ...

Predicting Survival in Idiopathic Pulmonary Fibrosis - ATS Journals

Reported prognostic indicators of survival in patients with IPF have been inconsistent in different studies. This is because most studies have ...

Assessment of the impact of social deprivation, distance to hospital ...

Idiopathic pulmonary fibrosis (IPF) is a progressive condition associated with a variable prognosis. The relationship between socioeconomic ...

Incidence, Prevalence, and Survival of Patients with Idiopathic ...

Recent developments in the care of patients with idiopathic pulmonary fibrosis have the potential to improve survival rates. Population-based ...

Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic ...

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease (ILD) associated with loss of lung function and high mortality. Two ...

Assessment of survival in patients with idiopathic pulmonary fibrosis ...

Conclusions: CT-histogram derived indexes may provide an accurate estimation of survival in IPF patients. They demonstrate a correlation with PFTs, highlighting ...

Real-World Study Analysing Progression and Survival of Patients ...

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and irreversible lung disease. Licensed treatment options for IPF are ...

Assessment of survival in patients with idiopathic pulmonary fibrosis ...

survival differences considering proposed cut-off points were also demonstrated according to kurtosis (p=0. ... HRCT analysis at diagnosis time. Conclusions: CT- ...

Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic ...

PURPOSE: Real-world studies have reported reduced mortality in patients with idiopathic pulmonary fibrosis (IPF) treated with antifibrotic therapy; however, ...